Joana Goncalves, Chief Medical Officer at Oruka Therapeutics, Inc. (ORKA), sold 7,000 shares at $84.36 ($604K) on 2026-07-15, disclosed to the SEC on 2026-07-15.
Scheduled sale ($604k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $84.36 | 400 | $34K | 5.6% |
| 2 | $85.86 | 2,497 | $214K | 35.5% |
| 3 | $86.68 | 3,803 | $330K | 54.6% |
| 4 | $87.25 | 300 | $26K | 4.3% |
| Total | $86.28 avg | 7,000 | $604K | 100% |
| Filing → |
| ORKA | SELL | 2026-06-15 | $551K | — | Filing → |
| ORKA | SELL | 2026-05-15 | $433K | — | Filing → |
| ORKA | SELL | 2026-04-15 | $463K | — | Filing → |